Literature DB >> 6998034

Corneal cytotoxicity of topically applied drugs, vehicles and preservatives.

N L Burstein.   

Abstract

The toxicity and side effects of drugs and their adjuncts are reviewed according to effect on corneal epithelium, stroma, and endothelium, when topically applied to healthy or wounded surfaces, or introduced into the anterior chamber of the eye. Corneal research techniques are reviewed, including scanning and transmission electron microscopy, electrophysiological techniques, and specular microscope observation. Clinical interpretation of these results is discussed. Reviews of specific toxicologic techniques and of medications are cited. Present research makes it increasingly apparent that not only medications but also their preservatives cannot be considered innocuous. Preservatives may be effective yet less damaging to the ocular integument when used at lower concentrations than those presently available commercially. Complete avoidance of preservatives by the use of special dispensing systems is found increasingly desirable.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6998034     DOI: 10.1016/0039-6257(80)90072-7

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  39 in total

1.  Bioavailability of fluorescein from a new drug delivery system in human eyes.

Authors:  A Steinfeld; A Lux; S Maier; R Süverkrüp; M Diestelhorst
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

2.  Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial.

Authors:  Arthur Shedden; Ingrid A Adamsons; Albert J Getson; Jean K Laurence; Christopher R Lines; David J Hewitt; Tony W Ho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

3.  Current practice pattern for dry eye patients in South Korea: a multicenter study.

Authors:  Jong Suk Song; Joon Young Hyon; Doh Lee; Euisang Chung; Chulyoung Choi; Jeongbok Lee; Hyo Myung Kim
Journal:  Korean J Ophthalmol       Date:  2014-03-14

4.  Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patients.

Authors:  D L Easty; G Nemeth-Wasmer; J-P Vounatsos; B Girard; N Besnainou; P Pouliquen; L Delval; J-F Rouland
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 5.  Adult keratoplasty: has the prognosis improved in the last 25 years?

Authors:  Francis W Price; Marianne O Price
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

6.  Phosphate concentration in artificial tears.

Authors:  W Bernauer; M A Thiel; U M Langenauer; K M Rentsch
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-18       Impact factor: 3.117

Review 7.  The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.

Authors:  Gerd Geerling; Joseph Tauber; Christophe Baudouin; Eiki Goto; Yukihiro Matsumoto; Terrence O'Brien; Maurizio Rolando; Kazuo Tsubota; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

8.  Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment.

Authors:  S Dinslage; M Diestelhorst; A Weichselbaum; R Süverkrüp
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

9.  Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis.

Authors:  Gennaro D'Angelo; Alessandro Lambiase; Magdalena Cortes; Roberto Sgrulletta; Roberta Pasqualetti; Ambra Lamagna; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-15       Impact factor: 3.117

10.  Frequent association of delayed tear clearance in ocular irritation.

Authors:  P Prabhasawat; S C Tseng
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.